ACT-EU News

The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

IMPORTANT MESSAGE FROM ACT EU

Nov 26, 2024 | ACT-EU News, Oncology News

All clinical trials expected to continue beyond 30 January 2025 must be transitioned to the EU Clinical Trials Regulation (CTR) via the Clinical Trials Information System (CTIS). This date marks the end of a three-year transition period that began when the CTR became...

Update from ACT EU: ACT EU Helpdesk For Non-Commercial Sponsors

Nov 1, 2024 | ACT-EU News

[ 💡 🔔 Updates from ACT EU: ACT EU Helpdesk For Non-Commercial Sponsors] ACT EU has established a dedicated helpdesk, which employs different measures to support non-commercial sponsors in navigating the clinical trial landscape in the EU. Currently, the...

ACT EU: ACT EU Helpdesk For Non-Commercial Sponsors

Oct 24, 2024 | ACT-EU News

ACT EU: Stakeholder Presentation on Critical Use-Cases at MSP Advisory Group Meeting (4 July 2024)

Aug 16, 2024 | ACT-EU News, CDDF News

On 4 July 2024, CDDF participated in a stakeholder presentation focused on critical use-cases at Multi-Stakeholder Platform (MSP) Advisory Group meeting. The session aimed to identify and discuss real-world challenges faced by stakeholder groups within the European...

ACT EU: Materials from MSP AG Meeting – 4 July 2024

Jul 10, 2024 | ACT-EU News, CDDF News

Check out presentation slides from the MSP AG Meeting that took place on 4 July 2024 and stay up to date on topics of interest for clinical trials in the EU. Multi-stakeholder platform – European Union (europa.eu)

ACT EU: Faster Access to Clinical Trial Information in Europe

Jun 19, 2024 | ACT-EU News, Oncology News

The launch of a new version of the Clinical Trials Information System (CTIS) is giving earlier and more efficient access to clinical trial information in Europe. Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000...

« Older Entries

Next Entries »